<DOC>
	<DOCNO>NCT02255279</DOCNO>
	<brief_summary>The administration adjuvanted Trivalent Influenza Vaccine ( aTIV ) come result immunogenic effective response compare conventional influenza vaccine elderly adult . The aim study evaluate safety immunogenicity Novartis aTIV child 6 &lt; 72 month age , Mexican population , comparison Fluzone , non-adjuvanted trivalent influenza vaccine ( TIV ) .</brief_summary>
	<brief_title>Safety Immunogenicity Adjuvanted Trivalent Influenza Vaccine Children 6 &lt; 72 Months Age Mexico .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals &gt; 6 month &lt; 72 month age day inform consent . Individuals whose parent ( ) /legal guardian ( ) voluntarily give write informed consent nature study explain accord local regulatory requirement , prior study entry . Individuals comply study procedure . Willingness allow serum sample store beyond study period , potential additional future test good characterize immune response . Progressive , unstable uncontrolled clinical condition . Hypersensitivity , include allergy , component vaccine , medicinal product medical equipment whose use foreseen study . History progressive severe neurologic disorder , seizure disorder GuillainBarr√© syndrome . Surgery plan study period Investigator 's opinion would interfere study visit schedule . Known bleed diathesis , condition may associate prolonged bleeding time . Any fatal prognosis underlie medical condition ( &lt; 12 month life expectancy ) . Clinical condition represent contraindication intramuscular vaccination blood draw . Abnormal function immune system result : 1 . Clinical condition . 2 . Systemic administration corticosteroid ( PO/IV/IM ) 14 consecutive day within 90 day prior informed consent . 3 . Administration antineoplastic immunomodulating agent radiotherapy within 90 day prior informed consent . Received immunoglobulin blood product within 180 day prior informed consent . Received investigational nonregistered medicinal product within 30 day prior informed consent . Study personnel immediate family household member . Any clinical condition , opinion investigator , might interfere result study pose additional risk subject due participation study . Received influenza vaccine ( licensed investigational ) laboratory confirm influenza within 6 month prior enrollment . Received vaccine within 14 day ( inactivated vaccine ) 28 day ( live vaccine ) prior enrolment study plan receive vaccine within 28 day study vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>71 Months</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>